
    
      This study will be carried on 60 participants with Type 2 Diabetes with age over 20 years.

      Participants will be classified into two groups:

        1. Group I (Interventional): treated with (NAC) dose of 1200 mg/day for two months in
           conjunction with conventional treatment.

        2. Group II (Non-interventional): control group receive conventional treatment.

      All patients will undergo the following:

        1. Full medical history will be taken.

        2. Laboratory investigations as follows:

      Blood samples will be collected for analysis after overnight fasting at the beginning and
      after 2 months of the study for determination of:

        1. Total cholesterol (T-chol).

        2. Plasma triglycerides (TG).

        3. High density lipoprotein cholesterol (HDL-C).

        4. Low density lipoprotein cholesterol (LDL-C).

        5. Fasting blood sugar.

        6. Blood urea nitrogen (BUN).

        7. Serum creatinine (SCr).

        8. Urine analysis.

        9. Glycated hemoglobin (HbA1c).

       10. Lipoprotein (a). In addition, blood pressure will be measured for 24 hr.
    
  